AURAL ANALYTICS, INC.
Objective acoustic speech analysis software that measures speech quality in neurological disorders using machine learning algorithms
- Sector
- Medtech
- Total capital
- $3.6M
- Federal grants
- $3.6M
- 6 awards · 2017–2023
- Rank in peer group#27 of 53
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 1
- 7 pending · first 2026
- Rank in peer group#23 of 53
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Automated objective outcome measures for clinical use in dysarthria$712K
- Federal grantHealth and Human S · Phase II · Automated objective outcome measures for clinical use in dysarthria$734K
- Federal grantNSF · Phase I · STTR Phase I: Remote assessment of respiratory function in hospital patients based on speech acoustics (COVID-19)$256K
- Federal grantNSF · Phase II · SBIR Phase II: A tool for estimating objective outcome measures in clinical speech applications$1.4M
- Federal grantHealth and Human S · Phase I · Automated objective outcome measures for clinical use in dysarthria$225K
- Federal grantNSF · Phase I · SBIR Phase I: A tool for estimating objective outcome measures in clinical speech applications$225K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 53 peers
Line = medianMedtech · Software
- Federal grants#27 · top 51%
- Granted patents#23 · top 43%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 1 granted of 8- GrantedTracking Articulatory And Prosodic Development In ChildrenUSPTOUS 12,609,131
- PendingSystems And Methods For Digital Speech-based Evaluation Of Cognitive FunctionUSPTOApplication 18553335
- PendingSystems And Methods For Estimation Of Forced Vital Capacity Using Speech AcousticsUSPTOApplication 18266563
Show all 8 patent records
- Tracking Articulatory And Prosodic Development In ChildrenApr 21, 2026 · US 12,609,131Granted
- Systems And Methods For Digital Speech-based Evaluation Of Cognitive FunctionJun 6, 2024 · Application 18553335Pending
- Systems And Methods For Estimation Of Forced Vital Capacity Using Speech AcousticsFeb 15, 2024 · Application 18266563Pending
- Systems And Methods For Assessing Speech, Language, And Social SkillsNov 23, 2023 · Application 18248349Pending
- Objective Assessment Of Speech And Respiration Changes After Smoking CessationApplication 62964642Pending
- Systems And Methods For Assessing Speech, Language, And Social SkillsApplication 63089482Pending
- Objective Assessment Of Patient Response For Calibration Of Therapeutic InterventionsApplication PCTUS2020053059Pending
- Objective Assessment Of Speech Resulting From Congestion Or DecongestionApplication 62964646Pending
Related companies, and why
- CARAWAY SOFTWARE, INC.Similar federal contract value in Medtech · null in contracts
- BEKEN BIO, INC.Similar federal contract value in Medtech · null in contracts
- ProtonintelSimilar federal contract value in Medtech · null in contracts
- NANOXORT LLCSimilar federal contract value in Medtech · null in contracts
- CHOSEN DIAGNOSTICS INCSimilar federal contract value in Medtech · null in contracts
- H3PELVIC THERAPY SYSTEMS, INC.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .